RESUMEN
In the article mentioned above an author's name was misspelled.
RESUMEN
Hypophosphatasia (HPP) is a rare inherited disorder of bone and mineral metabolism caused by loss of function mutations in the ALPL gene. The presentation in children and adults can be extremely variable and natural history is poorly understood particularly in adults. Careful patient evaluation is required with consideration of pharmacologic intervention in individuals meeting criteria for therapy. INTRODUCTION: The purposes of this review are to present current evidence regarding the diagnosis and management of hypophosphatasia in children and adults and provide evidence-based recommendations for management. METHOD: A MEDLINE, EMBASE, and Cochrane database search and literature review was completed. The following consensus recommendations were developed based on the highest level of evidence as well as expert opinion. RESULTS: Hypophosphatasia is a rare inherited disorder of bone and mineral metabolism due to loss of function mutations in the tissue non-specific alkaline phosphatase (ALPL) gene causing reductions in the activity of the tissue non-specific isoenzyme of alkaline phosphatase (TNSALP). Deficient levels of alkaline phosphatase result in elevation of inhibitors of mineralization of the skeleton and teeth, principally inorganic pyrophosphate. The impaired skeletal mineralization may result in elevations in serum calcium and phosphate. Clinical features include premature loss of teeth, metatarsal and subtrochanteric fractures as well as fragility fractures. Poor bone healing post fracture has been observed. Myalgias and muscle weakness may also be present. In infancy and childhood, respiratory and neurologic complications can occur. CONCLUSIONS: HPP is associated with significant morbidity and mortality. Pharmacologic intervention can result in significant clinical improvement. This Canadian position paper provides an overview of the musculoskeletal, renal, dental, respiratory, and neurologic manifestations of hypophosphatasia. The current state of the art in the diagnosis and management of hypophosphatasia is presented.
Asunto(s)
Hipofosfatasia/diagnóstico , Hipofosfatasia/tratamiento farmacológico , Fosfatasa Alcalina/sangre , Fosfatasa Alcalina/genética , Fosfatasa Alcalina/uso terapéutico , Biomarcadores/sangre , Terapia de Reemplazo Enzimático/métodos , Medicina Basada en la Evidencia/métodos , Humanos , Hipofosfatasia/genética , Inmunoglobulina G/uso terapéutico , Mutación , Fosfato de Piridoxal/sangre , Proteínas Recombinantes de Fusión/uso terapéutico , Análisis de Secuencia de ADN/métodosAsunto(s)
Genotipo , Mosaicismo , Neurofibromatosis 1/genética , Neurofibromina 1/genética , Fenotipo , Adolescente , Adulto , Biopsia , Niño , Femenino , Estudios de Asociación Genética , Pruebas Genéticas , Humanos , Masculino , Neurofibromatosis 1/diagnóstico , Neurofibromatosis 1/patología , Piel/patología , Adulto JovenRESUMEN
Ciliopathies, a growing pleotropic class of diseases due to mutations in genes that play an important role in primary cilia function. These highly conserved organelles are key to cell signaling. We now know, that mutations in one gene may lead to more than one ciliopathy phenotype and that one ciliopathy phenotype may be due to mutations in more than one gene. We studied the case of a female child with a novel ciliopathy phenotype and identified two novel mutations in the gene IFT80. Previously, mutations in IFT80 have been associated with a very narrow rib cage and failure of the lungs. Bone anomalies are also part of this IFT80-condition but with no vision problems documented. Our case had none of the features known to be associated with IFT80 mutations and had retinal degeneration (RD). This work broadens the IFT80-phenotype spectrum and also shows RD can be a feature of many ciliopathies.
Asunto(s)
Proteínas Portadoras/genética , Ciliopatías/genética , Mutación , Fenotipo , Degeneración Retiniana/genética , Secuencia de Aminoácidos , Proteínas Portadoras/química , Niño , Preescolar , Femenino , Humanos , Homología de Secuencia de AminoácidoRESUMEN
BACKGROUND AND PURPOSE: Neuroimaging features in neonates with RASopathies are rarely reported, and to date, there are no neuroimaging studies conducted in this population. Our aim was to investigate the occurrence of supratentorial and posterior fossa abnormalities on brain MRIs of neonates with a RASopathy. MATERIALS AND METHODS: An observational case-control study of neonates with a confirmed RASopathy was conducted. The presence of an intraventricular and/or parenchymal hemorrhage and punctate white matter lesions and assessments of the splenium of the corpus callosum, gyrification of the cortical gray matter, and enlargement of the extracerebral space were noted. The vermis height, transverse cerebellar diameter, cranial base angle, tentorial angle, and infratentorial angle were measured. RESULTS: We reviewed 48 brain MR studies performed at 3 academic centers in 3 countries between 2009 and 2017. Sixteen of these infants had a genetically confirmed RASopathy (group 1), and 32 healthy infants were enrolled as the control group (group 2). An increased rate of white matter lesions, extracerebral space enlargement, simplification of the cortical gyrification, and white matter abnormalities were seen in group 1 (P < .001, for each). The vermis height of patients was significantly lower, and tentorial and infratentorial angles were significantly higher in group 1 (P = .01, P < .001, and P = .001, respectively). CONCLUSIONS: Neonates with a RASopathy had characteristic structural and acquired abnormalities in the cortical gray matter, white matter, corpus callosum, cerebellum, and posterior fossa. This study provides novel neuroimaging findings on supratentorial and posterior fossa abnormalities in neonates with a RASopathy.
Asunto(s)
Encéfalo/diagnóstico por imagen , Encéfalo/patología , Enfermedades del Recién Nacido/diagnóstico por imagen , Enfermedades del Recién Nacido/patología , Proteínas ras/genética , Estudios de Casos y Controles , Femenino , Mutación de Línea Germinal , Humanos , Lactante , Recién Nacido , Enfermedades del Recién Nacido/genética , Imagen por Resonancia Magnética/métodos , Masculino , Neuroimagen , Sustancia Blanca/diagnóstico por imagen , Sustancia Blanca/patologíaAsunto(s)
Manchas Café con Leche/genética , Péptidos y Proteínas de Señalización Intracelular/genética , Proteínas de la Membrana/genética , Mosaicismo , Eliminación de Secuencia/genética , Proteínas Adaptadoras Transductoras de Señales , Adolescente , Manchas Café con Leche/diagnóstico , Diagnóstico Diferencial , Heterocigoto , Humanos , Masculino , Neurofibromatosis 1/diagnóstico , Neurofibromatosis 1/genéticaRESUMEN
Buschke-Ollendorff syndrome (BOS) is a rare, often benign, autosomal skin disorder. BOS commonly presents with nontender connective tissue naevi and sclerotic bony lesions (osteopoikilosis [OPK]). Herein, we summarize the presenting features of BOS and potential associations by conducting a systematic review of the literature and summarizing a cohort seen at the Hospital for Sick Children (HSC), Toronto, Canada. PubMed was searched using the following terms: 'BOS'; 'dermatofibrosis lenticularis'; 'OPK'; 'LEMD3'; 'elastoma'; 'collagenoma'. Only case reports were included, without date or language restrictions. Cases were further narrowed to those where patients or their families had a combination of skin and bony lesions, or a positive genetic test. Data were summarized using frequencies. In total, 594 reports were discovered, of which 546 (92%) were excluded. The remaining 48 accounted for 164 cases. Skin lesions were noted in 24% of cases and bony lesions in 20%, while 54% of patients had both. In 1% of cases the diagnosis was made on genetic testing alone. A family history was noted in 92% of cases. All patients with spinal stenosis (2%) or shortened status (7%) had OPK. Six per cent of patients had neurological problems. However, 50% of the cohort from HSC had cognitive delays, and only cases from 2007 onwards reported cognitive delays (the prevalence was 17% among those cases). This review confirms the classical diagnostic features of BOS. In addition, it highlights a previously unreported association between a shortened stature and OPK, as well as a possible association with cognitive delays.
Asunto(s)
Osteopoiquilosis/diagnóstico , Enfermedades Cutáneas Genéticas/diagnóstico , Adolescente , Adulto , Distribución por Edad , Edad de Inicio , Anciano , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Osteopoiquilosis/complicaciones , Enfermedades Cutáneas Genéticas/complicaciones , Adulto JovenRESUMEN
Genomic rearrangements at chromosome 13q31.3q32.1 have been associated with digital anomalies, dysmorphic features, and variable degree of mental disability. Microdeletions leading to haploinsufficiency of miR17â¼92, a cluster of micro RNA genes closely linked to GPC5 in both mouse and human genomes, has recently been associated with digital anomalies in the Feingold like syndrome. Here, we report on a boy with familial dominant post-axial polydactyly (PAP) type A, overgrowth, significant facial dysmorphisms and autistic traits who carries the smallest germline microduplication known so far in that region. The microduplication encompasses the whole miR17â¼92 cluster and the first 5 exons of GPC5. This report supports the newly recognized role of miR17â¼92 gene dosage in digital developmental anomalies, and suggests a possible role of GPC5 in growth regulation and in cognitive development.
Asunto(s)
Duplicación Cromosómica , Cromosomas Humanos Par 13 , Glipicanos/genética , MicroARNs/genética , Polidactilia/diagnóstico , Polidactilia/genética , Carácter Cuantitativo Heredable , Adulto , Hibridación Genómica Comparativa , Facies , Femenino , Humanos , Lactante , Masculino , Fenotipo , ARN Largo no CodificanteAsunto(s)
Ganglioneuroma/genética , Neurofibromatosis 1/genética , Neoplasias de la Columna Vertebral/genética , Preescolar , Análisis Mutacional de ADN , Familia , Femenino , Mutación del Sistema de Lectura , Ganglioneuroma/patología , Humanos , Intrones/genética , Mutación , Neurofibromatosis 1/patología , Neurofibromina 1/genética , Empalme del ARN , Neoplasias de la Columna Vertebral/patologíaRESUMEN
The identification of trisomy mosaicism in the prenatal setting is often shrouded with uncertainty for the genetic counsellor, and more importantly for the parents. The outcomes for these pregnancies may well be normal, but abnormalities and even in utero death are possibilities depending on the chromosomal abnormality and the degree of mosaicism. Advice to parents following the diagnosis of trisomy 16 mosaicism at chorionic villus sampling, with confirmation at subsequent amniocentesis, and in the setting of apparently normal fetal ultrasonography, is necessarily cautious. Malformations are seen in the majority of infants born following a diagnosis of mosaic trisomy 16 at amniocentesis, and intrauterine growth retardation, with postnatal catch-up, is the rule. We report here a case with a normal outcome by age 2.5 years and in fact with above-average language ability, and in whom trisomy mosaicism was confirmed postnatally.
Asunto(s)
Amniocentesis , Muestra de la Vellosidad Coriónica , Trisomía , Adulto , Desarrollo Infantil , Preescolar , Cromosomas Humanos Par 16/genética , Femenino , Retardo del Crecimiento Fetal/diagnóstico por imagen , Retardo del Crecimiento Fetal/genética , Humanos , Lactante , Recién Nacido , Mosaicismo , Embarazo , Trisomía/diagnóstico , Trisomía/genética , UltrasonografíaRESUMEN
BACKGROUND: Microarray genome analysis is realising its promise for improving detection of genetic abnormalities in individuals with mental retardation and congenital abnormality. Copy number variations (CNVs) are now readily detectable using a variety of platforms and a major challenge is the distinction of pathogenic from ubiquitous, benign polymorphic CNVs. The aim of this study was to investigate replacement of time consuming, locus specific testing for specific microdeletion and microduplication syndromes with microarray analysis, which theoretically should detect all known syndromes with CNV aetiologies as well as new ones. METHODS: Genome wide copy number analysis was performed on 117 patients using Affymetrix 250K microarrays. RESULTS: 434 CNVs (195 losses and 239 gains) were found, including 18 pathogenic CNVs and 9 identified as "potentially pathogenic". Almost all pathogenic CNVs were larger than 500 kb, significantly larger than the median size of all CNVs detected. Segmental regions of loss of heterozygosity larger than 5 Mb were found in 5 patients. CONCLUSIONS: Genome microarray analysis has improved diagnostic success in this group of patients. Several examples of recently discovered "new syndromes" were found suggesting they are more common than previously suspected and collectively are likely to be a major cause of mental retardation. The findings have several implications for clinical practice. The study revealed the potential to make genetic diagnoses that were not evident in the clinical presentation, with implications for pretest counselling and the consent process. The importance of contributing novel CNVs to high quality databases for genotype-phenotype analysis and review of guidelines for selection of individuals for microarray analysis is emphasised.
Asunto(s)
Análisis Citogenético , Variación Genética , Discapacidad Intelectual/diagnóstico , Pérdida de Heterocigocidad , Análisis por Micromatrices , Polimorfismo de Nucleótido Simple/genética , Dosificación de Gen , Perfilación de la Expresión Génica , Genoma Humano , Humanos , Discapacidad Intelectual/genéticaRESUMEN
The congenital disorders of glycosylation (CDG) are a rapidly expanding disease group with protean presentations. Specific end-organ involvement leads to significant morbidity and mortality, and the skeletal manifestations are often not appreciated, apart from the common association of osteopaenia with CDG-Ia. We performed a literature review of all documented skeletal manifestations in reported CDG patients, revealing a diverse range of skeletal phenotypes. We discuss the possible underlying mechanisms of these skeletal manifestations observed in CDG that are important and frequently under-recognized.
Asunto(s)
Enfermedades Óseas Metabólicas/etiología , Trastornos Congénitos de Glicosilación/complicaciones , Errores Innatos del Metabolismo de los Carbohidratos , Glicosilación , Humanos , Sistema Musculoesquelético/fisiopatología , FenotipoAsunto(s)
Enfermedades del Desarrollo Óseo/genética , Errores Innatos del Metabolismo/genética , Sustitución de Aminoácidos/genética , Enfermedades del Desarrollo Óseo/diagnóstico por imagen , Glicosilación , Humanos , Recién Nacido , Errores Innatos del Metabolismo/diagnóstico por imagen , Fosfotransferasas (Fosfomutasas)/genética , RadiografíaRESUMEN
A 9-year-old-girl who had herpes simplex encephalitis developed impending uncal herniation requiring surgical decompression. This case highlights the development of an uncommon complication despite the early initiation of treatment with acyclovir.